Home LiteratureArticle Details
PMID: 3258258 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Characterization of the human T lymphocyte adenosine receptor: comparison of normal and systemic lupus erythematosus cells.

Schultz LA, Kammer GM, Rudolph SA

Abstract

To determine whether a defect in the T cell response to adenosine exists at the level of the adenosine receptor in systemic lupus erythematosus (SLE) we measured the binding affinity and maximum binding of T cell membranes from both normal and SLE T cells by utilizing radiolabeled adenosine ligands. Normal T lymphocyte membranes possess a single class of [3H]5-N-ethylcarboxamide adenosine binding sites with a Kd of 0.61 microM, a Bmax of 23.5 pmol/mg protein, and a Hill coefficient of 0.98, which indicates the presence of noncooperative sites. In contrast, T cell membranes do not bind significant amounts of either [3H]cyclohexyladenosine or [3H]phenylisopropyladenosine. These data indicate that T lymphocyte membranes have only A2, and not A1, adenosine receptors. Similarly, T cells from both active and inactive SLE subjects also express only A2 receptors with a Kd of 0.93 microM, a Bmax of 20.4 pmol/mg protein, and a Hill coefficient of 0.85, which is consistent with the presence of noncooperative sites. There is no difference in the on-rate, affinity, or density of T cell A2 receptors from active SLE patients, inactive SLE patients, or healthy controls. We conclude that T lymphocytes from both healthy and SLE subjects express A2, but not A1, receptors. Thus, the inability of SLE T cells to respond to adenosine does not reflect a decreased density of A2 (stimulatory) receptors, diminished A2 receptor binding, or an increased affinity or number of A1 (inhibitory) adenosine receptors. These observations support the conclusion that the defect in the T cell cAMP-dependent pathway may occur at a point distal to the adenosine receptor.

MeSH Terms
Adenosine/analogs & derivatives,metabolism Adenosine-5'-(N-ethylcarboxamide) Binding Sites Binding, Competitive Cell Membrane/metabolism Female Humans Lupus Erythematosus, Systemic/metabolism,pathology Receptors, Purinergic/metabolism Reference Values T-Lymphocytes/metabolism
Chemicals
Receptors, Purinergic Adenosine-5'-(N-ethylcarboxamide) Adenosine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Schultz L A
Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.
Kammer G M
Rudolph S A
Article Info
Journal
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Abbr.
FASEB J
ISSN
0892-6638
Published
1988-03-01
Pages
244-50
Language
English
Region
United States
NLM ID
8804484
Subset
IM
Grants
NIADDK NIH HHS · AM-33072 · United States
NIAMS NIH HHS · AR-07505 · United States
NCRR NIH HHS · M01-RR-00080 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com